nach oben

Reactions Weekly

Erschienen in:

01.01.2021 | Case report

Multiple drugs

Myositis and cholestatic hepatitis: 6 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

In a review of the French PharmacoVigilance Database and in VigiBase, six patients [five females and one male including four patients aged 37−61 years; not all ages stated] were described, who developed myositis during treatment with adalimumab, methotrexate or infliximab. Additionally, one of the six patients developed cholestatic hepatitis during treatment with ciprofloxacin and pregabalin [routes not stated; not all indications, dosages, duration of treatments to reaction onsets and outcomes stated]. …

Gaboriau L, et al. Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases. Neuromuscular Disorders 30: 915-920, No. 11, Nov 2020. Available from: URL: http://doi.org/10.1016/j.nmd.2020.09.026

Titel: Multiple drugs
Myositis and cholestatic hepatitis: 6 case reports
Publikationsdatum: 01.01.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-88361-6

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Multiple drugs

Myositis and cholestatic hepatitis: 6 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Methylprednisolone

Cyclophosphamide/dexamethasone

Tacrolimus

Pembrolizumab

Pembrolizumab

Antibacterials/antifungals